Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells

Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein

Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide

Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report

Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells